Clinical Trial Update: Observational Study to Evaluate the Safety and Efficacy of Zepzelca™ Injection

View source ↗

Summary

Observational study to evaluate the safety and efficacy of Zepzelca (lurbinectedin) injection; sponsor is Boryung Pharmaceutical Co., Ltd, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Zepzelca (lurbinectedin)

Snippet

Sponsor: Boryung Pharmaceutical Co., Ltd | Conditions: SCLC | Status: RECRUITING